CytomX Therapeutics Inc (CTMX) — Defensive Interval Ratio
CytomX Therapeutics Inc (CTMX) has a Defensive Interval Ratio of 3210 days as of June 2026. Defensive assets of $350.55 Million (cash $-, short-term investments $313.06 Million, receivables $37.49 Million) cover 3210 days of daily cash needs of $109.21K/day. Explore CytomX Therapeutics Inc (CTMX) investment intensity to see how much of total assets are deployed in long-term investments.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
CytomX Therapeutics Inc Defensive Interval Ratio (2013–2025)
This chart shows how CytomX Therapeutics Inc's Defensive Interval Ratio has evolved across 13 annual periods from 2013 to 2025. As of June 2026, the ratio stands at 3210 days, meaning defensive assets of $350.55 Million can fund 3210 days of operations without new revenue. Read CytomX Therapeutics Inc (CTMX) financial obligations for a breakdown of total debt and financial obligations.
Annual Defensive Interval Ratio for CytomX Therapeutics Inc (2013–2025)
The table below presents the year-by-year Defensive Interval Ratio for CytomX Therapeutics Inc from 2013 to 2025, covering 13 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see CytomX Therapeutics Inc balance sheet assets.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 990 days | $126.40 Million | $127.71K/day | $- | $124.39 Million | ▲ +710 days |
| 2024 | 279 days | $65.67 Million | $234.99K/day | $- | $62.57 Million | ▼ -97 days |
| 2023 | 376 days | $160.77 Million | $427.16K/day | $- | $157.34 Million | ▲ +52 days |
| 2022 | 325 days | $135.68 Million | $418.10K/day | $- | $99.70 Million | ▼ -20 days |
| 2021 | 345 days | $100.49 Million | $291.28K/day | $- | $99.70 Million | ▼ -325 days |
| 2020 | 670 days | $125.06 Million | $186.61K/day | $- | $124.26 Million | ▲ +211 days |
| 2019 | 459 days | $107.73 Million | $234.49K/day | $- | $107.72 Million | ▼ -244 days |
| 2018 | 703 days | $188.65 Million | $268.24K/day | $- | $188.55 Million | ▼ -531 days |
| 2017 | 1234 days | $206.70 Million | $167.53K/day | $- | $196.56 Million | ▲ +421 days |
| 2016 | 812 days | $79.61 Million | $97.99K/day | $- | $77.29 Million | ▼ -2148 days |
| 2015 | 2960 days | $127.63 Million | $43.12K/day | $- | $126.89 Million | ▲ +2895 days |
| 2014 | 65 days | $1.98 Million | $30.58K/day | $- | $100.00K | ▲ +35 days |
| 2013 | 29 days | $337.00K | $11.43K/day | $- | $100.00K | — |